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Abstract 
Objective: To evaluate the impact of pharmacists, working collaboratively with patients, on blood pressure control, lifestyle goal 
setting, adherence to antihypertensive therapy, patient knowledge and satisfaction, and modification of cardiovascular risk factors.  
Methods:  Self-declared hypertensive patients met with the pharmacist for blood pressure monitoring, lifestyle goal setting, and 
education about medications and disease state on four occasions over a 6–month period.  
Practice innovation: A community pharmacy partnered with an employer wellness plan to provide education and monitoring for 
patients with hypertension based on home blood pressure readings obtained using monitors that wirelessly transmit information to 
the pharmacist. Main outcome measure(s): Percentage of patients at blood pressure goal, mean blood pressure, percentage of 
patients with lifestyle goals, medication adherence, patient knowledge and satisfaction, and modification of cardiovascular risk 
factors. Results: Patients not at their goal blood pressure at baseline had a significant decrease in blood pressure and a significant 
increase in achievement of their blood pressure goals. Across the population, no significant changes were seen in the primary 
outcome, lifestyle goals, medication adherence or modification of cardiovascular risk factors. Patient knowledge increased from 
baseline and satisfaction with the service was high. Conclusion: Blood pressure control improved in patients not at their treatment 
goal. All patients increased their knowledge about hypertension and reported high satisfaction with the pharmacy service. Pharmacy 
services should be offered to patients who are more likely to reap a benefit. Home blood pressure readings are useful to inform 
clinical decision making and supplement patient consultation within the pharmacy setting. 
 
 
Relevance and Contribution to Literature  
Over 74 million Americans have elevated blood pressure that 
warrants treatment.
1 Uncontrolled hypertension leads to end 
stage renal disease, heart failure, myocardial infarction, 
stroke, and is the number one attributable risk factor for 
death throughout the world.
2 Despite understanding the risks 
associated with hypertension, approximately 30 percent of 
adults are still unaware that they have hypertension, greater 
than 40 percent of individuals with hypertension are not  
being treated, and two-thirds of hypertensive patients on  
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medical therapy are not being controlled to their optimal  
blood pressure goals.
3 Non-adherence to lifestyle changes 
and medications has been identified as a barrier to optimal 
antihypertensive therapy.
4 
 
Patient education, simplifying regimens, and behavioral 
strategies to remind patients to take their medications have 
all been shown to improve adherence to medications and 
blood pressure control.
5 Pharmacists are in a unique position 
to provide education to patients with hypertension and to 
implement other strategies to improve adherence to lifestyle 
changes and medication regimens. Project ImPACT: 
Hypertension introduces a new element into pharmacist-
provided care by equipping patients with unique home blood 
pressure monitoring devices that can wirelessly transmit 
readings to the pharmacy computer. This information is used Original Research  PRACTICE-BASED RESEARCH 
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by the pharmacist when assembling a complete picture of 
that patient’s blood pressure control during face-to-face 
visits. Incorporating home blood pressure monitoring data 
provides the pharmacist with the unique teaching 
opportunity of relating treatment and monitoring with 
patient goal setting.  
 
Objective  
Project ImPACT: Hypertension created a value-based 
hypertension benefit, by partnering with an employer that 
includes appropriate financial incentives to employees to 
encourage their participation in the program, which includes 
education, monitoring, and counseling. This project utilized a 
model of patient-focused pharmacy care that incorporated 
structured visits, financial incentives, enhanced self-
monitoring, and disease state, lifestyle, and medication 
education. The objectives of Project ImPACT: Hypertension 
were to: 
  Assist identified patients with hypertension in 
achieving national treatment goals; 
  Increase nutritional, exercise, and weight loss goal 
setting among patients with hypertension; 
  Improve participant adherence to medication 
therapy; 
  Improve patient knowledge and health satisfaction; 
and, 
  Modify cardiovascular risk factors. 
 
Practice Setting  
University Pharmacy is an independently owned community 
pharmacy located on the campus of Wayne State University 
in Detroit, MI, employing one pharmacist and two 
technicians. The pharmacy focuses on a patient-centered 
approach to maximize medication adherence so patients 
reach their clinical goals and improve their quality of life. 
University Pharmacy strives to incorporate research and 
modern pharmacy practice to serve faculty, staff, and 
students of Wayne State University and those living in the 
metro-Detroit area. A dedicated consultation room at the 
pharmacy is equipped with patient assessment devices and 
serves as a private space for the provision of clinical 
pharmacy services. University Pharmacy’s owner and chief 
pharmacist is certified to administer immunizations, Clinical 
Laboratory Improvement Amendments (CLIA)–waived tests 
for cholesterol and diabetes monitoring, and Medication 
Therapy Management (MTM). Approximately 80% of her time 
is spent providing clinical services. In addition, she is a 
preceptor for Wayne State University and precepts 
approximately 8 six-week Advanced Pharmacy Practice 
Experiences per year. These students are integrally involved 
in providing clinical services to patients. 
  
Partnering with employers on health promotion programs 
provides an opportunity for pharmacy services to show a 
measurable impact and provide resources to improve patient 
adherence and participation. University Pharmacy has a 
history of partnering with Wayne State University to improve 
employee health through the Wellness Warriors Program. 
Wellness Warriors offers financial incentives to full-time 
Wayne State University employees to participate in health 
screenings, wellness coaching, and diet and exercise 
programs throughout the year. The University Pharmacy has 
provided the cardiovascular risk screening (including 
cholesterol, blood pressure, BMI, and healthy lifestyle) and 
immunizations to employees for the past 4 years.  
 
Methods 
This pharmacy hypertension service was offered to 
employees participating in the Wayne State Wellness 
Warriors Program. Information about the hypertension 
service was available during the Wellness Warrior health 
screenings which were available to all university employees. 
Banners were also present on the Wellness Warriors website 
with information about the program. University employees 
were eligible for this service if they were self-identified as 
having a diagnosis of hypertension or pre-hypertension. 
Patients did not qualify for this service if they were pregnant, 
nursing, under 18, or over 89 years of age. Partnering with 
the Wayne State University Wellness Warriors Program 
provided the opportunity to incentivize patients to complete 
the 6 month program. Patients received $50.00 from the 
Wellness Warriors at the completion of the follow-up, which 
was intended to provide resources for them to become 
empowered and to take control of their health. No payment 
was made directly from Wayne State University to the 
University Pharmacy. 
 
Participants enrolled in the pharmacy hypertension service 
met with the pharmacist or student pharmacist 4 times over a 
6–month period at the University Pharmacy. Visits were 
typically scheduled 6-weeks apart, but some scheduling 
adjustments were made to accommodate patient requests 
and clinical needs. Pharmacists and student pharmacists who 
were involved in the service were required to complete a 
training module and pass a competency exam. Prior to the 
first visit participants completed a medical intake form and a 
knowledge and health satisfaction survey. The first visit was 
45-60 minutes and subsequent visits were 15-30 minutes 
each. The majority of time during each visit was dedicated to 
education and coaching about blood pressure, lifestyle 
modifications, adherence, and goal setting. Patients were not 
only encouraged to be adherent to their medication therapy, 
but also to create realistic lifestyle goals. Additionally, the 
pharmacist or student pharmacist performed a clinical Original Research  PRACTICE-BASED RESEARCH 
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assessment; which included blood pressure measurement, 
weight, and an interview to assess goal setting and 
adherence. This data was recorded on a visit encounter form. 
The visit encounter form was also used to record any 
medication-related concerns identified by the pharmacist or 
student pharmacist, how they were addressed in the 
therapeutic plan, and the status of their resolution. Written 
letters were used to communicate directly with physicians. 
Patient education materials compiled by the American Heart 
Association and the National Institutes of Health were also 
provided to all participants. Activities performed during each 
visit are detailed in Table 1.  
 
At the end of the 6 months or after 4 visits, participants 
completed another knowledge and health satisfaction survey 
with additional questions regarding their perception of 
pharmacy services. The process of care was designed based 
on successful chronic disease modeling experiences from the 
APhA Foundation along with integration of JNC7 clinical 
practice guidelines.
6-13 Approval for this project and data 
collection was obtained from the Institutional Review Board 
of Wayne State University and informed consent was 
obtained from all patients. 
 
Practice Innovation  
Employees who participated in the pharmacy hypertension 
service were given a home blood pressure monitor (model 
number UA-851THW) and pedometer (model number (XL-
20), which are part of A&D Medical’s Wellness Connected
TM 
series. The devices had the capability to wirelessly transmit 
device data, including the complete set of home blood 
pressure measurements, to the pharmacy computer. The 
devices provided blood pressure measurements equivalent to 
those obtained by a trained observer using the 
cuff/stethoscope auscultation method within the limits 
prescribed by the American National Standards Institute for 
electronic or automated sphygmomanometers. The 
pharmacist trained patients to use the devices pursuant to 
the instructions that accompanied the devices. Patients were 
instructed to take their blood pressure according to the 
schedule provided by their primary care provider, or a 
minimum of once daily and when they felt that their blood 
pressure may be high. Patients were also instructed to keep a 
diary about activities that may have impacted any out-of-
range blood pressure readings.  
 
At each visit, the patient brought in the blood pressure 
devices and the pharmacist uploaded the data onto the 
pharmacy computer. A software program created a graph 
marked with color indicators to visually represent the 
patient’s readings in relation to goal. The color indicators 
were the same as those reported by the blood pressure 
monitored when used at home. The pharmacist used the 
green (at goal), yellow (borderline), orange (stage I 
hypertension), and red (stage II hypertension) indicators as a 
springboard for discussion with the patient about causes of 
blood pressure variability. Through these targeted 
conversations about the home readings and diary entries, the 
pharmacist was able to identify patterns and hypertensive 
triggers. Examples of patients’ triggers that were identified 
through the analysis of home blood pressure readings are 
described below: 
 
  One patient identified that the three to four beers 
he consumed on Saturday nights was causing an 
increase in his blood pressure. Further discussion 
with the pharmacist helped to clarify this behavior as 
binge drinking, as the patient did not drink any other 
day of the week. The pharmacist was able to help 
the man identify alcohol as a hypertensive trigger 
and modify his lifestyle to keep his blood pressure 
under control. 
  A few patients within the program reported that 
they were non-smokers. However, once the 
pharmacist began to identify a pattern of elevated 
home blood pressure readings, the patients revealed 
that they were occasional smokers. The pharmacist 
was able to use the graphs of the home readings to 
show the patients the impact smoking has on their 
blood pressures and how lifestyle modifications can 
improve their health. 
  One of the patients in the program was a professor. 
Through review of the downloaded blood pressure 
readings, the pharmacist identified a pattern of 
elevations in blood pressure at a specific time each 
week. With the help of the professor’s assistant, the 
professor identified that the elevation coincided 
with a standing appointment with one particular 
student. The pharmacist counseled the professor 
about stress management techniques to help keep 
blood pressure under control even during 
challenging situations. 
Although these are anecdotal examples, blood pressure 
monitor records contributed in-depth information about 
home readings that impacted clinical decision-making and 
education plans.  The daily readings and activity levels 
showed previously unidentified patterns and triggers of blood 
pressure variability.  Additionally, the use of the software that 
accompanied the wireless devices visually represented blood 
pressure control which highlighted the silent nature of 
hypertension and the impact of lifestyle.  Further projects 
and investigations to define the role of this technology and its 
impact on outcomes are warranted.  Original Research  PRACTICE-BASED RESEARCH 
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Main Outcome Measures 
The primary endpoints are targeted to show changes in 
participants’ blood pressure measurements, reported as the 
percentage of participants meeting blood pressure goal at 
baseline compared to the end of follow-up. Blood pressure 
goal, as defined by The Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure (JNC 7),
2 is a blood pressure 
<140/90 mmHg. In patients with concomitant diabetes or 
renal disease, the blood pressure goal is <130/80 mmHg. The 
change in average blood pressure for the group of 
participants is also reported. Blood pressure readings 
collected by the pharmacist or student pharmacist on the day 
of each visit were utilized as endpoint data for the purpose of 
analysis. 
 
Secondary endpoints included goal setting, medication 
adherence, patient knowledge and satisfaction, and 
modification of cardiovascular risk factors. Percentage of 
patients with goals related to nutrition, exercise, and weight 
loss, as well as percentage of patients who were adherent to 
therapy, were compared from the beginning to the end of the 
follow-up period. Goal setting and adherence to medication 
therapy was self-reported verbally to the pharmacist during 
visits, which was documented on the visit encounter form. 
Participants were designated as “having set goals” or “not 
having set goals” in the areas of nutrition, exercise, and 
weight loss. Participants were designated as “adherent” (< 6 
out of 30 days of missed medication) or “non-adherent.” 
Participant knowledge was determined by comparing pre- 
and post-intervention survey results. Satisfaction with 
pharmacist care was measured only at the completion of the 
follow-up period. Participant modification of cardiovascular 
risk factors was determined based on pharmacist-collected 
BMI data from baseline and follow-up visits as well as from 
pharmacist-patient interviews related to smoking status 
throughout the project. 
 
A Microsoft Access database was used for initial data analysis 
and summary statistics. SAS software was used for additional 
statistical analysis. Continuous data was analyzed using a 
paired t test and categorical data was analyzed using a Chi-
square or Fisher’s exact test where appropriate. The a priori 
level of significance was set at 0.05.  
 
Results  
A total of 152 participants chose to engage with this new 
health plan benefit. The average age for all patients was 51 
with an average BMI in the obese range. More African 
Americans than Caucasians were included, with a small 
number of other ethnic groups. At baseline, more than 80% 
of all patients reported that they were adherent to therapy 
and more than 75% reported having goals for nutrition, 
exercise, and weight loss (Table 2). The overall population 
demonstrated no significant differences in the primary 
endpoints. In addition, no differences in goal setting, 
adherence, or cardiovascular risk factor reduction were 
realized (Table 3).  
 
According to survey data from baseline compared to the final 
visit, perceptions of disease state knowledge were improved 
in all areas from baseline. At the end of follow-up, 
significantly more patients reported that it is important to: 
take their blood pressure medications and manage their 
blood pressure through diet and exercise. In addition, more 
patients felt informed about their blood pressure diagnosis, 
blood pressure goals, and signs and symptoms of heart 
attacks and strokes (Table 4). In addition, after participation, 
patient satisfaction with pharmacy services was high in all 
participants, with 99.2% of patients agreeing that they would 
recommend others to pursue a hypertension pharmacy 
service. 
 
A subgroup of patients who were not at their blood pressure 
goal at baseline (n=62) was evaluated post hoc. Baseline 
characteristics were similar among the subgroup and the full 
study population (Table 2).  The subgroup of patients had a 
significant reduction in blood pressure from baseline to the 
end of follow-up. (Table 5). There were no significant changes 
in goal setting, adherence, or cardiovascular risk factor 
reduction in the subgroup. 
 
Discussion 
The benefits of pharmacy involvement in the care of 
hypertensive patients have been reported as early as 1973.
14 
Since that time, the impact of pharmacist involvement in the 
management and outcomes in patients with hypertension has 
been demonstrated in multiple settings showing 
improvements in blood pressure control and other 
cardiovascular risk factors.
15,16 Pharmacists have notably been 
reported to have significant impact on hypertension control 
rates when electronically engaged with patients for 
consultation in combination with web-based education and 
home blood pressure monitoring.
17
 Most recently, home 
blood pressure telemonitoring along with pharmacist-
provided management and dosage adjustments have 
significantly improved hypertension control in patients.
18  
 
In the current report, participating patients were self-
identified as pre-hypertensive or hypertensive and 
enrollment may have been based more on incentives 
provided than a true health care need. Subsequently, the 
average blood pressure for the patients in the project was 
132/83. When patients were analyzed based on their baseline Original Research  PRACTICE-BASED RESEARCH 
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blood pressure, patients not at goal experienced a benefit 
from this pharmacy intervention. This finding supports a 
nuanced approach to pharmacy services which selects 
patients who would glean the most benefit from an 
intervention. This is congruent with previous studies 
demonstrating a blood pressure benefit which included 
patients with blood pressures that were higher or not at 
goal.
19, 20  
 
There was no demonstrated difference in self-reported goal 
setting or self-reported medication adherence. Baseline goal 
setting and adherence was high, with over 75% of patients 
with lifestyle goals and over 80% of patients reported that 
they were adherent to medication therapy.  High baseline 
rates and maintenance of commitment to the goals over the 
6-month program may be due to participant selection from 
patients already engaged in the Wellness Warriors Program, 
in which lifestyle and wellness are key topics. Due to the self-
reported nature of the goals, limited conclusions can be 
drawn from this data. Although goal setting is not a common 
outcome in evaluation of pharmacist impact, pharmacists 
should embrace the opportunity to champion lifestyle 
interventions in a comprehensive approach to improving 
hypertension outcomes.
21 Future studies should evaluate goal 
setting and pharmacist impact on patient’s ability to 
formulate appropriate lifestyle goals and to achieve them.  
 
This structured interaction with the pharmacist resulted in a 
significant improvement in patient knowledge. As evidenced 
by the survey results, after completion more patients felt 
they understood their diagnosis of hypertension and knew 
their blood pressure goal. They had a greater understanding 
of the importance of medication adherence, diet, and 
exercise in the management of hypertension. Additionally, 
they were more aware of the complications of hypertension, 
how to recognize them, and when to seek medical attention. 
Time spent with the pharmacist reviewing home blood 
pressure readings and relating them to personal triggers may 
have positively impacted the patient’s knowledge about 
hypertension and ability to retain information about 
management of the condition. Although medication 
adherence rates did not significantly improve, several studies 
have documented that knowledge deficits relating to 
hypertension often play a role in reduced medication 
adherence and worse blood pressure control.
22-24  However, 
changes in adherence with educational efforts have 
historically been difficult to demonstrate.
16, 25  
 
Limitations 
A key limitation to this report that deserves discussion is that 
the duration was 4 visits or 6 months in length. This time 
frame was potentially inconsistent between patients due to 
scheduling changes that caused deviations from the 6-week 
recurring appointment schedule. Six months was likely 
adequate to see some change in blood pressure but may not 
have been long enough to see changes in cardiovascular risk 
factors such as BMI or smoking status. Assessing patient 
satisfaction with the pharmacy service only at the end of the 
study period did not allow for conclusions regarding a change 
in patient’s perceptions because of the service, but only their 
willingness to recommend the pharmacy service to others.  
Patients were not followed after the completion of the four 
visits so it is unknown if the positive effects seen on blood 
pressure or hypertension knowledge would persist over time. 
An additional limitation is that the $50 payment from 
Wellness Warriors at the completion of 4 visits may have 
incentivized attending visits but not actively working toward 
improved health. Finally, the non-inclusion of a matched 
control group, lack of baseline satisfaction data for 
comparative purposes, and moderate number of patients 
achieving goal following the intervention, suggest that a 
rigorous clinical study may provide additional valuable 
evidence of results that began to emerge during this local 
implementation. 
 
Conclusion 
This pharmacy hypertension service resulted in improved 
blood pressure control in patients who were not at their 
treatment goal. All patients demonstrated an increase in their 
knowledge about hypertension and its treatment and 
expressed high satisfaction with the pharmacy service. As 
demonstrated here and in the recent study by Magolis 
published in JAMA
18, the use of home blood pressure 
monitoring devices that can transmit information to 
pharmacists and the integration of reports based on this 
information into the routine patient care services can support 
pharmacists as they help patients reach and maintain blood 
pressure goals. 
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Table 1: Visit activities 
 
Visit 
Hypertension 
Knowledge 
Survey 
Review of 
Home 
Blood 
Pressure 
Readings 
Visit 
Encounter 
Form 
Education 
Provided 
Identify and address 
medication related 
problems 
Perception of 
Pharmacist’s 
Care 
1  X    X  X  X   
2    X  X  X  X   
3    X  X  X  X   
4  X  X  X  X  X  X 
 
 
 
 
 
Table 2:  Baseline Characteristics 
 
  All participants  
(n=152) 
Not at goal at baseline 
(n=62) 
Age (years)  51.3 ± 8.9  51.3 ± 8.1 
% Male  29.6%  32.3% 
BMI  33.4 ± 8.6 (n=143)  34.0 ± 7.5 (n = 58) 
Race (ethnicity) 
-  African American 
-  Caucasian 
-  Asian/Pacific Islander 
-  Hispanic 
-  Not Specified 
 
44.7% 
40.1% 
5.3% 
1.3% 
8.6% 
 
54.8% 
37.1% 
4.8% 
0.0% 
3.2% 
% Smokers  7.9%  4.8%     
Blood pressure goal 
-  % <140/90 
-  % <130/80 
 
81.6% 
17.8% 
 
61.3% 
37.1% 
Total number of visits  3.8 ± 0.6  3.7 ± 0.7 
Average time for first visit (minutes)  52.0 ± 12.0  53.5 ± 10.9 
Average time for follow-up visits (minutes)  27.8 ± 11.4  28.4 ± 12.5 
Baseline systolic blood pressure (mmHg)  132.3 ± 19.7  148.2  ± 18.6 
Baseline diastolic blood pressure (mmHg)  83.4 ± 11.2  92.2 ± 9.4 
Baseline % adherent to therapy  82.2%  86.6% 
Baseline % with goals 
-  Nutrition 
-  Exercise 
-  Weight 
 
76.3% 
84.9% 
80.9% 
 
75.8% 
80.6% 
85.5% 
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Table 3: Primary and Secondary Outcomes for all participants (n=152, unless otherwise indicated) 
 
  Baseline  End of follow-up  Change  P value 
Primary Outcomes 
% at blood pressure 
goal 
59.2%  55.9%  -3.3%  P=0.19 
Mean systolic blood 
pressure ± SD 
(mmHg) 
132.3 (19.7)  131.5 (16.6)  -0.8 (15.2)  P=0.25 
Mean diastolic 
blood pressure ± SD 
(mmHg) 
83.4 (11.2)  82.6 (10.0)  -0.8 (8.6)  P=0.14 
Secondary Outcomes 
% with nutrition 
goals 
76.3%  78.3%  +2.0%  P=0.34 
% with exercise 
goals 
84.9%  80.9%  -4.0%  P=0.16 
% with weight goals  80.9%  75.0%  -5.9%  P=0.09 
% adherent (n=131)  93.4%  97.4%  +4.0%  P<0.05 
% smoker  7.2%  6.6%  -0.6%  P=0.28 
BMI (n=125)  33.4  33.6  +0.2  P=0.08 
 
 
 
 
 
 
Table 4: Patient Perceptions of Disease State Knowledge 
 
Question  Agree* at 
Baseline, n(%) 
Agree* Post, 
n(%) 
P value 
My overall health is good.  75 (61.0)  89 (72.4)  P=0.06 
Overall, it is important to take my blood pressure 
medications. 
99 (84.6)  112 (97.4)  P<0.001 
I feel well informed about my diagnosis of high blood 
pressure. 
71 (59.2)  115 (95.8)  P<0.001 
A healthy diet and exercise are necessary in managing my 
high blood pressure. 
108 (87.8)  123 (100)  P<0.001 
I know my blood pressure goals.  68 (59.1)  123 (100)  P<0.001 
I know the signs and symptoms of a stroke.  72 (62.1)  116 (94.3)  P<0.001 
I know the signs and symptoms of a heart attack.  84 (71.8)  117 (95.1)  P<0.001 
I know what to do if I experience the signs or symptoms of 
a stroke or heart attack. 
63 (53.8)  110 (89.4)  P<0.001 
Pre and post surveys were available for 123 participants. Not all surveys were complete. 
 *Agree = ‘Agree’ or ‘Strongly Agree’ on 5 point Likert scale, or yes for “yes/no” question.  
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Table 5: Subgroup of Patients not at BP Goal at Baseline 
 
  Baseline  End of follow-up  Change  P value 
Patients not at goal at baseline (n=62) 
% at blood 
pressure goal 
0%  21.0%  +21.0%  P<0.001 
Mean systolic 
blood pressure ± 
SD (mmHg) 
148.2 (18.6)  141.0 (17.0)  -7.3 (16.5)  P<0.001 
Mean diastolic 
blood pressure ± 
SD (mmHg) 
92.2 (9.4)  87.8 (9.4)  -4.4 (8.5)  P<0.001 
 
 